Brief: 3-Year Clinical Outcomes And Bph Subgroup Analysis Of Profound Medical’S Phase I Clinical Trial To Be Included In Presentation At Dgu 2018

Profound Medical

18/09/2018 22:22

Sept 18 (Reuters) - Profound Medical Corp  PRN.TO :
    * 3-YEAR CLINICAL OUTCOMES AND BPH SUBGROUP ANALYSIS OF
PROFOUND
MEDICAL’S PHASE I CLINICAL TRIAL TO BE INCLUDED IN PRESENTATION
AT DGU 2018

Source text for Eikon:  ID:nGNX4q5RrL 
Further company coverage:  PRN.TO 

 ((Briefs@thomsonreuters.com;))